Advances in Geriatric Oncology: Toward Optimized Cancer Care

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Palliative and Supportive Care".

Deadline for manuscript submissions: 31 August 2025 | Viewed by 1052

Special Issue Editor


E-Mail Website
Guest Editor
Hull York Medical School, University of Hull, Hull HU6 7RU, UK
Interests: oncogeriatrics; thoracic oncology; mesothelioma

Special Issue Information

Dear Colleagues, 

The global numbers of elderly cancer patients are dramatically increasing. This presents a huge challenge to health care professionals in terms of managing older patients with multiple age-related comorbidities. This often biases clinicians against treating elderly cancer patients. This has led several centres to embed oncogeriatric services in their oncology service. Further solutions include prehabilitation strategies, including exercise to improve fitness for systemic anticancer therapy. Today, many anticancer therapies are much more effective, and elderly patients can expect to live longer. This creates an additional strain on the system, in that these patients need a more protracted follow-up.

It is also important to realise the under-representation of elderly patients in clinical trials. This can cause problems with the implementation of trial findings in elderly cancer patients, as was the case with immune checkpoint inhibitors.

In this Special Issue, original research articles and reviews in the area of Geriatric Oncology are welcome.

I look forward to receiving your contributions.

Prof. Dr. Michael J. Lind
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oncogeriatrics
  • clinical trials
  • prehabilitation
  • elderly cancer patients
  • cancer care

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 583 KiB  
Article
Implementation of a Multi-Disciplinary Geriatric Oncology Clinic in Toronto, Canada
by Ines B. Menjak, Khloe Campos, Mark Pasetka, Arlene Budden, Elaine Curle, Leslie Gibson, Ewa Szumacher and Rajin Mehta
Curr. Oncol. 2025, 32(2), 89; https://doi.org/10.3390/curroncol32020089 - 6 Feb 2025
Viewed by 743
Abstract
Older adults with cancer tend to face more complex health needs than their younger counterparts. Patients > 65 years of age are recommended for comprehensive geriatric assessment (CGA) to capture and address age-related vulnerabilities. Access to geriatrics services is limited, and our baseline [...] Read more.
Older adults with cancer tend to face more complex health needs than their younger counterparts. Patients > 65 years of age are recommended for comprehensive geriatric assessment (CGA) to capture and address age-related vulnerabilities. Access to geriatrics services is limited, and our baseline audit of geriatric referrals in 2019 from the cancer program revealed that only 30% of patients referred received a CGA. The aim of this study was to assess the implementation of a geriatric oncology (GO) clinic that employs CGA and determine patient outcomes. We conducted a retrospective cohort study at a single institution. Data collection included baseline characteristics, GO clinic findings and characteristics, recommendations/referrals, and emergency room (ER) visits/hospitalizations within 6 months of CGA. Descriptive statistics were used for analysis. A total of 100 patients were included, with a median (range) age of 80 (63–97) years; 70% were female, and the most common cancer type was breast (31%). Through the GO clinic, patients were seen in a timely manner, with a median of 3 weeks, compared to our historical baseline of 11 weeks. Cognitive decline (32%) and pre-treatment CGA (22%) were the most common reasons for referral, and the most common new diagnosis was cognitive impairment (65%). For pre-treatment CGA, 16 (48%) patients were deemed suitable for treatment and 10 (30%) were recommended for modified treatment; 34 (94%) referring physicians followed the recommendation. In addition, most (68%) patients received an allied health referral. One third of patients visited the ER and 30 (30%) patients were hospitalized. Overall, the GO clinic resulted in greater access to CGA in a timely manner, enhanced access to allied health, and assisted in treatment decision-making. Full article
(This article belongs to the Special Issue Advances in Geriatric Oncology: Toward Optimized Cancer Care)
Show Figures

Figure 1

Back to TopTop